Metraipolis › archive › dc_7b34790dd92f

Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma — Europe PMC PMID:28066715

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/28066715
DOI
10.3389/fonc.2016.00259
License (as archived)
solo-consultazione
Archived
2026-10-08T06:04:16.218Z
SHA-256 of the archived text
a74e150ecaab69f52e2a7c3fae5f531adf05549ef585018acf3bb9e8fdbd738b
Stable URL of this page
https://metraipolis.com/documento/dc_7b34790dd92f

How to cite

Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma — Europe PMC PMID:28066715 — Europe PMC (en), https://europepmc.org/article/MED/28066715 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7b34790dd92f (Metraipolis archive dc_7b34790dd92f, sha256 a74e150ecaab69f52e2a7c3fae5f531adf05549ef585018acf3bb9e8fdbd738b)
BibTeX
@misc{dc7b34790dd92f,
  title = {Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma — Europe PMC PMID:28066715},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/28066715},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7b34790dd92f; sha256 a74e150ecaab69f52e2a7c3fae5f531adf05549ef585018acf3bb9e8fdbd738b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/28066715. Agents can read the archived copy with the MCP tool read_document.